Stock MNPR MONOPAR THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Monopar Therapeutics Inc.

Equities

MNPR

US61023L1089

Delayed Nasdaq
Other stock markets
 12:04:33 2024-05-17 EDT 		5-day change 1st Jan Change
0.6103 USD -1.17% Intraday chart for Monopar Therapeutics Inc. -9.21% +79.39%
05-09 Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-16 Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Monopar Therapeutics Announces Resignation of Andrew P. Mazar as Member of the Board of Directors, Effective April 8, 2022
CI
Monopar Therapeutics Inc. Appoints Octavio Costa as Chief Medical Officer
CI
Monopar Therapeutics Inc. Appoints Andrew Cittadine as Chief Operating Officer
CI
Monopar Therapeutics Inc. Appoints Laura Kelly as Director of Clinical Operations
CI
Monopar Therapeutics Inc. Announces Termination of Employment of Kirsten Anderson, Senior Vice President of Clinical Development
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MNPR Stock
  4. News Monopar Therapeutics Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW